These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

456 related articles for article (PubMed ID: 15286366)

  • 1. APOBEC-mediated editing of viral RNA.
    Bishop KN; Holmes RK; Sheehy AM; Malim MH
    Science; 2004 Jul; 305(5684):645. PubMed ID: 15286366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. APOBEC deaminases as cellular antiviral factors: a novel natural host defense mechanism.
    Franca R; Spadari S; Maga G
    Med Sci Monit; 2006 May; 12(5):RA92-8. PubMed ID: 16641889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts.
    Mangeat B; Turelli P; Caron G; Friedli M; Perrin L; Trono D
    Nature; 2003 Jul; 424(6944):99-103. PubMed ID: 12808466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiviral potency of APOBEC proteins does not correlate with cytidine deamination.
    Bishop KN; Holmes RK; Malim MH
    J Virol; 2006 Sep; 80(17):8450-8. PubMed ID: 16912295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retroviral restriction by APOBEC proteins.
    Harris RS; Liddament MT
    Nat Rev Immunol; 2004 Nov; 4(11):868-77. PubMed ID: 15516966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional central polypurine tract provides downstream protection of the human immunodeficiency virus type 1 genome from editing by APOBEC3G and APOBEC3B.
    Wurtzer S; Goubard A; Mammano F; Saragosti S; Lecossier D; Hance AJ; Clavel F
    J Virol; 2006 Apr; 80(7):3679-83. PubMed ID: 16537639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. APOBEC-mediated viral restriction: not simply editing?
    Holmes RK; Malim MH; Bishop KN
    Trends Biochem Sci; 2007 Mar; 32(3):118-28. PubMed ID: 17303427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutagenesis of apobec-1, the catalytic subunit of the mammalian apolipoprotein B mRNA editing enzyme, reveals distinct domains that mediate cytosine nucleoside deaminase, RNA binding, and RNA editing activity.
    MacGinnitie AJ; Anant S; Davidson NO
    J Biol Chem; 1995 Jun; 270(24):14768-75. PubMed ID: 7782343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extensive editing of a small fraction of human T-cell leukemia virus type 1 genomes by four APOBEC3 cytidine deaminases.
    Mahieux R; Suspène R; Delebecque F; Henry M; Schwartz O; Wain-Hobson S; Vartanian JP
    J Gen Virol; 2005 Sep; 86(Pt 9):2489-2494. PubMed ID: 16099907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The enzymatic activity of CEM15/Apobec-3G is essential for the regulation of the infectivity of HIV-1 virion but not a sole determinant of its antiviral activity.
    Shindo K; Takaori-Kondo A; Kobayashi M; Abudu A; Fukunaga K; Uchiyama T
    J Biol Chem; 2003 Nov; 278(45):44412-6. PubMed ID: 12970355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Death by deamination: a novel host restriction system for HIV-1.
    Goff SP
    Cell; 2003 Aug; 114(3):281-3. PubMed ID: 12914693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ancient adaptive evolution of the primate antiviral DNA-editing enzyme APOBEC3G.
    Sawyer SL; Emerman M; Malik HS
    PLoS Biol; 2004 Sep; 2(9):E275. PubMed ID: 15269786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA deamination: not just a trigger for antibody diversification but also a mechanism for defense against retroviruses.
    Harris RS; Sheehy AM; Craig HM; Malim MH; Neuberger MS
    Nat Immunol; 2003 Jul; 4(7):641-3. PubMed ID: 12830140
    [No Abstract]   [Full Text] [Related]  

  • 14. Advantages and disadvantages of cytidine deamination.
    Cascalho M
    J Immunol; 2004 Jun; 172(11):6513-8. PubMed ID: 15153462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of hepatitis B virus replication by APOBEC3G.
    Turelli P; Mangeat B; Jost S; Vianin S; Trono D
    Science; 2004 Mar; 303(5665):1829. PubMed ID: 15031497
    [No Abstract]   [Full Text] [Related]  

  • 16. Cytidine deamination and resistance to retroviral infection: towards a structural understanding of the APOBEC proteins.
    Huthoff H; Malim MH
    Virology; 2005 Apr; 334(2):147-53. PubMed ID: 15780864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heat shock proteins stimulate APOBEC-3-mediated cytidine deamination in the hepatitis B virus.
    Chen Z; Eggerman TL; Bocharov AV; Baranova IN; Vishnyakova TG; Kurlander R; Patterson AP
    J Biol Chem; 2017 Aug; 292(32):13459-13479. PubMed ID: 28637869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the differential context-dependence of DNA deamination by APOBEC enzymes: correlation with mutation spectra in vivo.
    Beale RC; Petersen-Mahrt SK; Watt IN; Harris RS; Rada C; Neuberger MS
    J Mol Biol; 2004 Mar; 337(3):585-96. PubMed ID: 15019779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Asymmetric Modification of Hepatitis B Virus (HBV) Genomes by an Endogenous Cytidine Deaminase inside HBV Cores Informs a Model of Reverse Transcription.
    Nair S; Zlotnick A
    J Virol; 2018 May; 92(10):. PubMed ID: 29491156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The cytidine deaminases AID and APOBEC-1 exhibit distinct functional properties in a novel yeast selectable system.
    Krause K; Marcu KB; Greeve J
    Mol Immunol; 2006 Feb; 43(4):295-307. PubMed ID: 15963568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.